Social Media Ideas for Embo Molecular Medicine

Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe

Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability studies in Europe. The post Merck’s new BioReliance® Faci...

European Medical Center (EMC): Moscow’s Premier JCI-Accredited Healthcare Ecosystem

Founded in 1989, the European Medical Center (EMC) is Russia’s flagship private healthcare group, uniting a network of modern multidisciplinary centers across Moscow. Trusted by mo...

How Evox Therapeutics is targeting CNS diseases with exosomes

Our guest today is Dr. Per Lundin, CEO of Evox Therapeutics, a UK biotech using engineered exosomes to deliver genetic medicines directly into the brain. The post How Evox Therapeu...

<![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

<![CDATA[The Future of Precision Medicine Depends on More Than Biology]]>

From Images to Data

This eBook introduces the latest trends in quantitative spatial biology and how IMC is accelerating their adoption and success. The post From Images to Data appeared first on GEN -...

Flicking the Switch: Five Scientists Honored at 2026 Warren Alpert Foundation Symposium for Hemoglobinopathy Research

Stuart Orkin, MD, and his former trainees Vijay Sankaran, MD, PhD, and Daniel Bauer, PhD, were joined by Swee-Lay Thein, MD, PhD, and John Tisdale, MD, both at the NIH. Their contr...

DNA Typewriter, PEtracer Map Mouse Development Through Organogenesis

Two DNA-recording systems traced cellular family trees across mouse embryogenesis, offering new insight into how organs form and when developing cells commit to specific fates. The...

<![CDATA[MRD Testing Is Becoming the Most Important Tool in Oncology Drug Development: Q&A with Eric Matthews]]&g...

From Discovery to Development

The articles in this eBook examine key trends driving this transformation, from AI-enabled discovery and experimental validation to advanced cell, gene, and biologic platforms, and...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult provided its investment and expert support to help two biotech companies accelerate the development of new treatments for a range of autoimmune, inflam...

Andelyn Curator Biomanufacturing Platform Supports Fayuvi Gene Therapy Approval

Sanfilippo syndrome type A (MPS IIIA) is a rare, fatal lysosomal storage disease that primarily affects the central nervous system and is marked by rapid neurodegeneration beginnin...

Springer Nature Honours Standout Editors Shaping Scientific Publishing in 2026

Springer Nature has announced its 2026 Editor of Distinction Awards, honouring dozens of editors, including a large cohort from BMC Geriatrics, for rigorous peer review management...

Preclinical Pulse: The research catching our eye in October 2026

Find out about six preclinical assets that caught our attention in the October edition of Labiotech's Preclinical Pulse. The post Preclinical Pulse: The research catching our eye i...

<![CDATA[Beyond Amyloid, Part Two (of two): Delivery, Diagnostics and the Path to Combination Care]]>

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genom...

The Metabolic Moment: 3 big bets to watch in metabolic disease

Explore three big bets in metabolic disease: the race to challenge Lilly and Novo, a pill that mimics exercise, and a gene therapy for diabetes. The post The Metabolic Moment: 3 bi...

Advancing Brain Organoids from Research Models to Scalable Platforms

In this GEN webinar, Joseph Shultz (VP of technical development and manufacturing, Ottimo Pharma) and Imroz Ghangas (VP of commercial sales, Asimov) discuss strategies for achievin...

Regenerative Medicine in the Bronze Age: MSCs and MSC-EVs Leading the Way

The field of regenerative medicine is gaining momentum. Mesenchymal stem cells (MSCs) remain central to this field, with expanding applications as direct therapies and as producers...

Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics

Researchers captured the first high-resolution 3D images of the muscle cell calcium channel RyR1 at six stages of opening inside the intact sarcoplasmic reticulum membrane, potenti...

HeartBeat.bio and Cubase Bio Partner to Advance 3D Spatial Transcriptomics for Cardiovascular Drug Discovery

HeartBeat.bio and Cubase Bio are combining cardiac organoids with 3D spatial transcriptomics and RNA sequencing to study...

Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples

Researchers showed how optical metabolic imaging (OMI) can be used to characterize metabolic activity within immune cells from the peripheral blood of patients, which could potenti...

Thirty Million Compartments: Testing Single-Molecule PCR’s Potential

Countable Labs has named Fred Hutchinson its first certified service provider, currently serving researchers across the Seattle region. And the company is continuing to build its l...

<![CDATA[From Direct-to-Patient to Direct-to-Disease: New Commercialization Models in Europe]]>